BMO Capital raised the firm’s price target on CSX to $38 from $37 and keeps an Outperform rating on the shares. The company’s Q4 results were in line, while its FY24 outlook was consistent with the firm’s forecast, the analyst tells investors in a research note. CSX volume momentum and operational improvement are showing progress, though BMO doesn’t expect incremental margins to strengthen until the back half of FY24, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CSX: